Stem cell patents: A landscape analysis

Nature Biotechnology

Volumn 27, Issue 8, 2009, Pages 722-726

  Konski, Antoinette F ^a   Spielthenner, Doris J F ^b  

^a FOLEY AND LARDNER LLP   (United States)

^b IDU Consult   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; EMBRYONIC STEM CELL; FUNDING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; NEURAL STEM CELL; PATENT; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL; UNITED STATES;

ANIMALS; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; PATENTS AS TOPIC; STEM CELLS;

EID: 68449088160     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0809-722     Document Type: Short Survey

References (11)

1. Obama, B. Removing barriers to responsible scientific research involving human stem cells (The White House, Washington, DC, March 9, 2009).
2. Wong, K.M. Cell Stem Cell 4, 95-96 (2009).
3. Anonymous. President Obama issues executive order on embryon ic stem ce 11 research - policy change generates new opportunities and challenges (Foley & Lardner Legal News Alert, Chicago, March 2009).
4. Anonymous. Stem cell research (National Conference of State Legislatures, Washington, DC, January 2008).
5. Anonymous. State funding of embryonic & fetal research as of January, 2008 (Kaiser Family Foundation, Washington, DC, January 2008).
6. News at CIRM. CIRM provides $40 million to support future stem cell scientists, June 18, 2009.
7. Takahashi, K. et al. Cell 131, 861-872 (2007).
8. Yu.J. et al. Science 318, 1917-1920 (2007).
9. Batagelj, V. et al. (eds.) Analyzing the structure of US patents, in Studies in Classification, Data Analysis, and Knowledge Organization 141-148 (Springer, New York, 2007).
10. Hall, B.H., Jaffe, A.B. & Trajtenberg, M. Rand J. Econ. 36, 16-38 (2005).
11. Bergman, K. & Graff, G.D. Nat. Biotechnol. 25, 419-424 (2007).